Answer
Yes, patients with HIV-1 taking emtricitabine/tenofovir disoproxil may still develop opportunistic infections and other HIV complications, so they should remain under close observation by physicians experienced in treating HIV-associated diseases.
Sources for this answer
- Emtricitabine/Tenofovir disoproxil Lupin 200 mg/245 mg Film-coated TabletsLupin Healthcare (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked